This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Coeliac disease and miscarriage

Authoring team

Up to 50% of women with untreated Coeliac disease (CD) refer an experience of miscarriage or an unfavorable outcome of pregnancy (1).

Gasbarrini, et al. (1) reported that 8% (3 out of 40 studied patients) of the CD prevalence in females with recurrent spontaneous abortions, defined as the presence of 2 or more consecutive spontaneous abortions of unknown origin.

In adult patients with CD, the disease has insidious clinical manifestations with few symptoms and the pregnancy may be considered a 'trigger' to unmask CD (2), that it may be considered as 'latent'.

 

Reference:

  • Gasbarrini A, Torre ES, Trivellini C, De Carolis S, Caruso A, Gasbarrini G. Recurrent spontaneous abortion and intrauterine fetal growth retardation as symptoms of coeliac disease. Lancet 2000; 356: 399- 400.
  • Collin P, Vilska S, Heinonen PK, Hallstrom O, Pikkarainen P. Infertility and celiac disease. Gut 1996; 39: 382-84

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.